HOME
ABOUT
PIPELINE
NEWS & EVENTS
- News Releases
- Events
PARTNERSHIPS
FCOI
CONTACT

TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.

Post navigation

Inhibition of RND-Type Efflux Pumps Confers the FtsZ-Directed Prodrug TXY436 with Activity against Gram-Negative Bacteria.

Pharmacokinetics and in Vivo Antistaphylococcal Efficacy of TXY541, a 1-Methylpiperidine-4-Carboxamide Prodrug of PC190723.

Search for:

Copyright © 2014-2022
TAXIS Pharmaceuticals, Inc.

HOME
ABOUT
PIPELINE
NEWS
PARTNERSHIPS
FCOI
CONTACT
Research & Development